DIA 2023: Returning Patient Data
In an interview at the 2023 DIA annual meeting with ACT editor, Andy Studna, Jean Sposaro, program lead, TransCelerate BioPharma, and director, global drug development operations industry collaborations, Bristol Myers Squibb discusses key takeaways from a session she moderated, "Returning Individual Participant Data: A Cultural and Operational Shift Towards Personalized Clinical Trial Options." Sposaro also touches on the concept of "data dumping," which was brought up at the session by David Leventhal, enterprise clinical trial data sharing lead, global data dissemination, Pfizer.
A more in-depth recap of the session itself can be found here.
SCOPE Summit 2025: Enhancing the Patient Experience Through Site Centricity
February 12th 2025In an interview with ACT senior editor Andy Studna at SCOPE Summit, Ashley Davidson, vice president, product lead - sponsor tech strategy, Advarra, highlights the need for more site-centric approaches in study startup.
SCOPE Summit 2025 Opening Keynote Panel: What Do Real Patients Actually Talk About?
February 3rd 2025Interactive panel on day 1 of SCOPE Summit 2025 highlighted the need for inclusive narratives, social listening to understand patient experiences, and the role of advocacy groups in opening doors to clinical trials.
